my community channel

Register to store your favourite programmes, receive schedule alerts, sign up for factsheets, participate in forums and much more...

What's On

Sat 22nd Nov 2008
	15:00	The Street Where You Live
	15:25	Volunteer Films 2008
	15:30	New Consumer TV
	16:00	UN Westminster & N.Y. Film Fest.
	16:55	Volunteer Films 2008

full schedule

Home

Your Charity Space

Squiffy's Space

This item viewed 734 times

Other entries by Squiffy:

Results 1 - 5 of 190

About Squiffy

Webmaster and Discussion Board Administrator for the Multiple Sclerosis Resource Centre. http...

more...

Multiple Sclerosis: early treatment can delay progression of the disease

Create new blog

ENS Meeting 2008 - Some patients do not have access to effective modern treatments.

The latest findings in the diagnosis and treatment of neurological diseases are under discussion among over 3,000 experts at the annual congress of the European Neurological Society (ENS) in Nice. Special attention is being paid to multiple sclerosis. Around 400,000 people in Europe suffer from the chronic inflammatory disease multiple sclerosis (MS). MS is the most common neurological illness in young adults. In many cases, the disease is still diagnosed too late. That has dramatic consequences, since many studies have demonstrated that early treatment with Beta-Interferon or Glatiramer Acetate can significantly slow the progress of inflammation. MS patients in some European countries are denied access to effective therapies, especially in the early stages of the disease, according to experts at the ENS Congress.................

For the complete report please go to MSRC: MS Research News : Drugs

Comments

There are no comments currently....

You must login to leave comments...

Last Updated ( Monday, 09 June 2008 )

back to Your Charity Space

donate

send us feedback